Inovio Pharmaceuticals (INO) Competitors $1.36 -0.03 (-2.16%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.38 +0.01 (+1.10%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO vs. MRNA, TLSI, PROF, CVRX, KRMD, ELMD, LNSR, PDEX, AVR, and RCELShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Moderna (MRNA), TriSalus Life Sciences (TLSI), Profound Medical (PROF), CVRx (CVRX), KORU Medical Systems (KRMD), Electromed (ELMD), LENSAR (LNSR), Pro-Dex (PDEX), Anteris Technologies Global (AVR), and Avita Medical (RCEL). These companies are all part of the "medical" sector. Inovio Pharmaceuticals vs. Its Competitors Moderna TriSalus Life Sciences Profound Medical CVRx KORU Medical Systems Electromed LENSAR Pro-Dex Anteris Technologies Global Avita Medical Moderna (NASDAQ:MRNA) and Inovio Pharmaceuticals (NASDAQ:INO) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings. Do insiders and institutionals believe in MRNA or INO? 75.3% of Moderna shares are held by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. 11.0% of Moderna shares are held by insiders. Comparatively, 2.3% of Inovio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is MRNA or INO more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Moderna's net margin of -105.67%. Moderna's return on equity of -28.69% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Moderna-105.67% -28.69% -21.94% Inovio Pharmaceuticals N/A -136.93%-89.99% Which has stronger valuation and earnings, MRNA or INO? Inovio Pharmaceuticals has lower revenue, but higher earnings than Moderna. Moderna is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModerna$3.14B4.14-$3.56B-$8.73-3.85Inovio Pharmaceuticals$220K226.69-$107.25M-$3.19-0.43 Which has more volatility & risk, MRNA or INO? Moderna has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Does the media refer more to MRNA or INO? In the previous week, Moderna had 14 more articles in the media than Inovio Pharmaceuticals. MarketBeat recorded 21 mentions for Moderna and 7 mentions for Inovio Pharmaceuticals. Moderna's average media sentiment score of 0.72 beat Inovio Pharmaceuticals' score of 0.54 indicating that Moderna is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moderna 9 Very Positive mention(s) 6 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Inovio Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend MRNA or INO? Moderna currently has a consensus target price of $46.61, indicating a potential upside of 38.56%. Inovio Pharmaceuticals has a consensus target price of $8.80, indicating a potential upside of 547.06%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Inovio Pharmaceuticals is more favorable than Moderna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moderna 4 Sell rating(s) 17 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SummaryModerna beats Inovio Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$49.88M$2.93B$5.55B$9.09BDividend YieldN/A2.41%5.25%4.02%P/E Ratio-0.4320.8528.2620.27Price / Sales226.69266.95408.79151.98Price / CashN/A42.1137.1257.67Price / Book0.727.638.045.49Net Income-$107.25M-$55.05M$3.19B$250.45M7 Day Performance-5.23%8.43%3.62%4.79%1 Month Performance-32.00%8.14%5.98%9.59%1 Year Performance-87.98%1.62%29.39%16.41% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals4.1219 of 5 stars$1.36-2.2%$8.80+547.1%-88.0%$49.88M$220K-0.43320Analyst ForecastHigh Trading VolumeMRNAModerna4.2999 of 5 stars$29.90-1.9%$46.61+55.9%-72.3%$11.56B$3.24B-3.425,800Trending NewsAnalyst ForecastTLSITriSalus Life Sciences3.0255 of 5 stars$4.96-2.2%$10.75+116.7%-9.4%$187.69M$29.43M-4.43106Positive NewsPROFProfound Medical2.7315 of 5 stars$6.09+2.0%$11.50+88.8%-37.3%$183.00M$10.68M-4.99150CVRXCVRx3.0925 of 5 stars$6.59+0.2%$14.50+120.0%-29.7%$171.56M$52.87M-3.02160News CoverageAnalyst RevisionKRMDKORU Medical Systems2.6902 of 5 stars$3.67+1.4%$4.50+22.6%+31.3%$169.33M$33.65M-33.3680Positive NewsELMDElectromed0.8706 of 5 stars$20.12-3.2%$38.00+88.9%+31.8%$168.73M$61.44M26.83160LNSRLENSAR1.3037 of 5 stars$12.84-2.4%$15.00+16.8%+167.0%$151.41M$57.07M-2.65110News CoveragePDEXPro-Dex2.5041 of 5 stars$46.22-3.3%$56.00+21.2%+153.3%$150.68M$53.84M16.51140Positive NewsHigh Trading VolumeAVRAnteris Technologies GlobalN/A$3.48-8.4%$16.50+374.1%N/A$137.04M$2.70M0.00138Gap UpRCELAvita Medical1.3625 of 5 stars$5.17-4.6%$16.50+219.1%-39.1%$136.64M$64.25M-2.36130 Related Companies and Tools Related Companies Moderna Alternatives TriSalus Life Sciences Alternatives Profound Medical Alternatives CVRx Alternatives KORU Medical Systems Alternatives Electromed Alternatives LENSAR Alternatives Pro-Dex Alternatives Anteris Technologies Global Alternatives Avita Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INO) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INO Stock Alerts